FIELD: medicine.
SUBSTANCE: estimating a probability of the Helicobacter pylori infection is ensured by taking a biomaterial (K4), diagnosing a gastrointestinal disease (K3), age (K1) and H.pylori O-antigen (Oag) in the biomaterial by the co-agglutination reaction followed by deriving a coefficient (K2) depending on the current calendar year; thereafter, PIO is calculated by formula PIO= SF×K1×K2×K3×K4, wherein SF, a seasonal fluctuation, makes 50 in the first month of the year, 61 in the 2nd, 55 in the 3rd, 31 in the 4th, 28 in the 5th, 14 in the 6th, 12 in the 7th, 15 in the 8th, 25 in the 9th, 45 in the 10th, 64 in the 11th, 58 in the 12th; K1 makes 0.5, if the patient is aged one year or less, or K1 makes 1.0, if the patient is aged more than one year; K2 makes Oag 0.5 in 2013; Oag 0.4 in 2014; Oag 0.3 in 2015; Oag 0.4 in 2016; Oag 0.5 in 2017; Oag 0.6 in 2018; Oag 0.6 in 2019; depending on a disease K3 makes: - apparently healthy - 1.0; - gastrointestinal diseases - 1.2; - non-ulcer dyspepsia - 1.3; - chronic gastroduodenitis - 1.5; - gastric and duodenal ulcer - 1.8; - atrophic gastritis - 1.3; depending on the biomaterial, K4 makes: - coprofiltrate - 1.0; - saliva - 1.2; - blood serum circulating immune complex - 1.4, and if PIO falls within the range of 1 to 9%, the probability of H.pylori infection is considered to be doubtful, the PIO value of 10 to 19% shows the low probability; the PIO value of 20 to 39% shows the moderate probability, while if the PIO value is 40 to 100%, the probability is high.
EFFECT: method enables estimating the probability of the Helicobacter pylori infection by the non-invasive method.
2 tbl, 4 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROBABILITY DETERMINATION OF BECOMING INFECTED WITH HELICOBACTER PYLORI | 2007 |
|
RU2360251C1 |
METHOD FOR EVALUATING RISK OF EXACERBATIONS OF HELICOBACTERIOSIS | 2011 |
|
RU2481584C2 |
METHOD FOR PREPARING TEST-SYSTEM FOR DETERMINATION OF HELICOBACTER PYLORI CYTOTOXIN-ASSOCIATED PROTEIN ANTIGENS IN BIOLOGICAL MATERIAL IN INFECTED PATIENTS BY CO-AGGLUTINATION REACTION | 2002 |
|
RU2232989C1 |
METHOD OF PREPARING DIAGNOSTICUM FOR DETECTION OF HELICOBACTER PYLOPI ANTIGEN IN COAGGLUTINATION REACTION | 2000 |
|
RU2186394C2 |
METHOD OF PREPARING DIAGNOSTICUM FOR DETECTION OF CAMPYLOBACTER THERMOSTABLE ANTIGENS | 1996 |
|
RU2086984C1 |
METHOD OF CONDUCTING COAGLUTINATION REACTION | 0 |
|
SU1182400A1 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
METHOD OF PREDICTING EFFECT OF INFLIXIMAB THERAPY IN CHILDREN WITH CROHN'S DISEASE | 2013 |
|
RU2533435C1 |
PROGNOSIS OF BRONCHIAL ASTHMA RISK | 2004 |
|
RU2275863C1 |
MEDICINE OF CHILD GEE'S DISEASE SEVERITY LEVEL DETERMINATON | 2007 |
|
RU2333495C1 |
Authors
Dates
2014-12-20—Published
2012-11-20—Filed